NCT02350751View on ClinicalTrials.gov

Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Influenza
Interventions
DRUG

MEDI8852

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY